In 2021, Uganda introduced seasonal malaria chemoprevention (SMC) using sulfadoxine-pyrimethamine and amodiaquine (SPAQ). In 2022, SMC was scaled-up to eight districts in the Karamoja region where malaria transmission is highly seasonal, targeting over 200,000 children 3–59 months. SMC medicines were delivered by village health teams (VHTs) using a door-to-door approach over five monthly cycles. A full course of SPAQ was completed over a three-day period. Caregivers administered day 1 doses as directly observed treatment (DOT), supervised by VHTs, while day 2 and 3 doses were administered independently by caregivers.
This poster was presented at the 72nd annual meeting of the American Society of Tropical Medicine and Hygiene.
Country: UgandaKeywords: ASTMH | Malaria | Case management | Quality improvement | SMC
« Back to Publications